Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-16
DOI
10.1038/s41467-022-31044-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
- (2021) Yuyan Jiang et al. Nature Communications
- Prolonged activation of innate immune pathways by a polyvalent STING agonist
- (2021) Suxin Li et al. Nature Biomedical Engineering
- Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
- (2021) Chi Zhang et al. Nature Communications
- Carbon-coated FeCo nanoparticles as sensitive magnetic-particle-imaging tracers with photothermal and magnetothermal properties
- (2020) Guosheng Song et al. Nature Biomedical Engineering
- A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy
- (2020) Di-Wei Zheng et al. Nature Communications
- Electromagnetic nanomedicines for combinational cancer immunotherapy
- (2020) Kanyi Pu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches
- (2020) Elizabeth A. Thompson et al. Annual Review of Medicine
- Applications of focused ultrasound in the brain: from thermoablation to drug delivery
- (2020) Ying Meng et al. Nature Reviews Neurology
- Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells
- (2020) Ling Li et al. Nature Biomedical Engineering
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
- (2019) Xiaoyun Li et al. Nature Reviews Clinical Oncology
- Photoactivatable Organic Semiconducting Pro-nanoenzymes
- (2019) Jingchao Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
- (2019) Wenwen Yue et al. Nature Communications
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Ultrasound Activated Sensitizers and Applications
- (2019) Xiahui Lin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
- (2019) Chi Zhang et al. ACS Nano
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
- (2018) Kuangda Lu et al. Nature Biomedical Engineering
- Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
- (2018) Yu Chao et al. Nature Biomedical Engineering
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Re-examining the Nature and Function of Self-Reactive T cells
- (2016) David M. Richards et al. TRENDS IN IMMUNOLOGY
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells
- (2011) Marie-Luce De Temmerman et al. BIOMATERIALS
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents
- (2011) Jonathan F. Lovell et al. NATURE MATERIALS
- Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature
- (2010) Olivier Lidove et al. GENETICS IN MEDICINE
- The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
- (2009) J. M. Wilson et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started